血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法)
Multiplex Assay Kit for Thrombomodulin (TM) ,etc. by FLIA (Flow Luminescence Immunoassay)
CD141; THBD; BDCA3; THRM; Fetomodulin
(注:单次混测多因子不超过8个指标 )
- 编号LMA529Hu
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 实验方法双抗夹心
- 反应时长3.5h
- 检测范围2.93-3000pg/mL
- 灵敏度最小可检测剂量小于等于0.977 pg/mL.
- 样本类型Plasma
- 下载 英文说明书 中文说明书
- 规格 8指标数 7指标数 6指标数 5指标数 4指标数 3指标数 2指标数1指标数
- 价格 ¥ 2359 ¥ 2449 ¥ 2586 ¥ 2767 ¥ 2948 ¥ 3221 ¥ 3629 计算器 ¥ 4536 添加到价格计算器
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
本试剂盒用于检测血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
回收率
分别于定值血清及血浆样本中加入一定量的血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
样本 | 回收率范围(%) | 平均回收率(%) |
serum(n=5) | 80-99 | 80 |
EDTA plasma(n=5) | 86-102 | 91 |
heparin plasma(n=5) | 92-101 | 96 |
sodium citrate plasma(n=5) | 91-99 | 96 |
精密度
精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%
线性
在定值血清及血浆样本内加入适量的血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法)含量的测定值与理论值的比率。
样本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 91-101% | 85-103% | 81-91% | 78-104% |
EDTA plasma(n=5) | 80-90% | 95-105% | 84-101% | 89-103% |
heparin plasma(n=5) | 89-96% | 78-101% | 83-93% | 93-105% |
sodium citrate plasma(n=5) | 78-99% | 91-101% | 83-92% | 91-99% |
稳定性
经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
实验流程
1. 实验前标准品、试剂及样本准备;
2. 加样(标准品、样本、磁珠)标准品或样本100μL及磁珠10μL,
37°C酶标板振荡器孵育90分钟;
3. 磁吸甩干,加检测溶液A100μL,37°C酶标板振荡器孵育60分钟;
4. 磁吸洗板3次;
5. 加检测溶液B100μL,37°C振动孵育30分钟;
6. 磁吸洗板3次;
7. 加鞘液100μL,旋涡震荡2分钟后读数。
实验原理
将血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法)抗体包被于磁珠,制成固相载体,向微孔中分别加入标准品或标本以及磁珠,其中的血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法)与连接于固相载体上的抗体结合,然后加入生物素化的血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法)抗体,将未结合的生物素化抗体洗净后,加入PE标记的亲和素,再次彻底洗涤后即可上机读数。MFI值和样品中的血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法)呈正相关。
赠品
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
APA529Hu61 | 血栓调节蛋白(TM)活性蛋白 | Cell culture; Activity Assays. |
RPA529Hu03 | 血栓调节蛋白(TM)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA529Hu02 | 血栓调节蛋白(TM)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA529Hu62 | 血栓调节蛋白(TM)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA529Hu01 | 血栓调节蛋白(TM)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA529Hu01 | 血栓调节蛋白(TM)多克隆抗体 | WB; IHC; ICC; IP. |
PAA529Hu02 | 血栓调节蛋白(TM)多克隆抗体 | WB; IHC; ICC; IP. |
PAA529Hu03 | 血栓调节蛋白(TM)多克隆抗体 | WB; IHC; ICC; IP. |
LAA529Hu71 | 血栓调节蛋白(TM)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAA529Hu22 | 血栓调节蛋白(TM)单克隆抗体 | WB; IHC; ICC; IP. |
MAA529Hu25 | 血栓调节蛋白(TM)单克隆抗体 | WB; IHC; ICC; IP. |
MAA529Hu27 | 血栓调节蛋白(TM)单克隆抗体 | WB; IHC; ICC; IP. |
MAA529Hu28 | 血栓调节蛋白(TM)单克隆抗体 | WB |
MAA529Hu29 | 血栓调节蛋白(TM)单克隆抗体 | WB |
MAA529Hu21 | 血栓调节蛋白(TM)单克隆抗体 | WB; IHC; ICC; IP. |
RAA529Hu21 | 血栓调节蛋白(TM)重组抗体 | WB; IFC; IHC; IP. |
MAA529Hu23 | 血栓调节蛋白(TM)单克隆抗体 | WB; IHC; ICC; IP. |
MAA529Hu24 | 血栓调节蛋白(TM)单克隆抗体 | WB; IHC; ICC; IP. |
FAA529Hu52 | 抗血栓调节蛋白(TM)单克隆抗体(别藻蓝蛋白标记) | FCM |
SEA529Hu | 血栓调节蛋白(TM)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA529Hu | 血栓调节蛋白(TM)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
PLoS One | A Non-Lethal Traumatic/Hemorrhagic Insult Strongly Modulates the Compartment-Specific PAI-1 Response in the Subsequent Polymicrobial Sepsis [PubMed: PMC3568129] |
Clin Appl Thromb Hemost. | Is There Any Association Between Thrombosis and Tissue Factor Pathway Inhibitor Levels in Patients With Vitamin D Deficiency? [Pubmed: 24203351] |
медицинские науки | КЛЕТОЧНО-МОЛЕКУЛЯРНЫЕ МАРКЕРЫ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ И СИСТЕМНОГО ГЕМОСТАЗА ПРИ ВИБРАЦИОННОЙ БОЛЕЗНИ В … [Ru:Source] |
FASEB J. | Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice [Pubmed:24451386] |
Gynecol Endocrinol. | The effect of hormone therapy on biochemical and ultrasound parameters associated with atherosclerosis in 46, XY DSD individuals with female phenotype [Pubmed:24911331] |
Informa Healthcare | Changes in cardiac thrombomodulin and heat shock transcription factor 1 expression and peripheral thrombomodulin and catecholamines during hypothermia in rats [Pubmed:25109347] |
Bone Marrow Transplant. | Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen [Pubmed:25243628] |
Biomed Res Int | Basic Fibroblast Growth Factor Ameliorates Endothelial Dysfunction in Radiation-Induced Bladder Injury [PubMed: 26351640] |
Molecular Nutrition & Food Research | Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptors [PubMed: 25546502] |
Acta Biomater | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: an in vitro osteoblast-osteoclast-endothelial cell co-culture study [PubMed: 26689470] |
MEDICINE AND EDUCATION IN SIBERIA | КЛЕТОЧНО-МОЛЕКУЛЯРНЫЕ МАРКЕРЫ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ И СИСТЕМНОГО ГЕМОСТАЗА ПРИ ВИБРАЦИОННОЙ БОЛЕЗНИ В СОЧЕТАНИИ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ [Cozo: Mos] |
Acta Biomaterialia | Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast–osteoclast–endothelial cell co-culture study [Pubmed:26689470] |
Bone Marrow Transplantation | The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective functionand prevents SOS in a murine model. [pubmed:27427915] |
BMC Vet Res. | Blood markers of fibrinolysis and endothelial activation in canine babesiosis. [pubmed:28363279] |
Haematologica | Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain [Pubmed:29903766] |
Biomedicine & Pharmacotherapy | Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells [Pubmed:29775893] |
Scientific Reports | Association between Upper-airway Surgery and Ameliorative Risk Markers of endothelial function in obstructive Sleep Apnea [Pubmed: 31882827] |
Intensive Care Medicine Experimental | Preservation of renal endothelial integrity and reduction of renal edema by aprotinin does not preserve renal perfusion and function following experimental … [34169407] |